Plasma DNA as a potential biomarker for breast cancer detection

Breast cancer is a major malignancy among Indonesian women. It is often diagnosed in the later stages of cancer, which leads to poor prognosis and survival of the patients. This study investigated plasma DNA concentration as a potential biomarker for breast cancer. The benefit of using this detectio...

Full description

Bibliographic Details
Main Authors: Dewajani Purnomosari, Ulfah Dian Indrayani, . Irianiwati, Dian Caturini Sulistyoningrum
Format: Article
Language:English
Published: Universitas Gadjah Mada 2016-12-01
Series:Journal of the Medical Sciences
Subjects:
Online Access:https://jurnal.ugm.ac.id/bik/article/view/15931
id doaj-3b281a9c122d4e459a90977f70d9ebe3
record_format Article
spelling doaj-3b281a9c122d4e459a90977f70d9ebe32020-11-24T21:54:45ZengUniversitas Gadjah MadaJournal of the Medical Sciences0126-13122356-39312016-12-0148410.19106//JMedSci00480420160311771Plasma DNA as a potential biomarker for breast cancer detectionDewajani Purnomosari0Ulfah Dian Indrayani. IrianiwatiDian Caturini SulistyoningrumFaculty of Medicine Universitas Gadjah MadaBreast cancer is a major malignancy among Indonesian women. It is often diagnosed in the later stages of cancer, which leads to poor prognosis and survival of the patients. This study investigated plasma DNA concentration as a potential biomarker for breast cancer. The benefit of using this detection is the cost-effectiveness and the samples can be collected from patients using non-invasive methods. Plasma samples were obtained from healthy controls (n=18) and cancer patients (n=22). Each sample was split into two equal portions for DNA isolation using two different methods for the NaI method and a commercially available kit (Qiagen/ QA) method. The DNA concentration was determined by using a GeneQuant spectrophotometer (Pharmacia). The t-test was used for statistical analysis, which was performed using the SPSS 17.0 software. Compared to the commercial method, extraction using NaI yielded higher DNA concentration, both from samples of healthy controls and cancer patients (p=0,008 and p=0.000, respectively). Furthermore, regardless of the isolation method used, the plasma DNA concentration was higher in healthy controls than in cancer cases (p=0,032 and p=0.005, for NaI and QA methods, respectively). In conclusion, isolation methods significantly affect DNA concentrations. The plasma DNA concentration of healthy controls is significantly higher than those of the cancer cases, suggesting that plasma DNA concentration might be a potential biomarker for breast cancer detection with less invasive sampling method than tissue biopsies.https://jurnal.ugm.ac.id/bik/article/view/15931plasma DNAbiomarkerdetectionbreast cancerliquid biopsy
collection DOAJ
language English
format Article
sources DOAJ
author Dewajani Purnomosari
Ulfah Dian Indrayani
. Irianiwati
Dian Caturini Sulistyoningrum
spellingShingle Dewajani Purnomosari
Ulfah Dian Indrayani
. Irianiwati
Dian Caturini Sulistyoningrum
Plasma DNA as a potential biomarker for breast cancer detection
Journal of the Medical Sciences
plasma DNA
biomarker
detection
breast cancer
liquid biopsy
author_facet Dewajani Purnomosari
Ulfah Dian Indrayani
. Irianiwati
Dian Caturini Sulistyoningrum
author_sort Dewajani Purnomosari
title Plasma DNA as a potential biomarker for breast cancer detection
title_short Plasma DNA as a potential biomarker for breast cancer detection
title_full Plasma DNA as a potential biomarker for breast cancer detection
title_fullStr Plasma DNA as a potential biomarker for breast cancer detection
title_full_unstemmed Plasma DNA as a potential biomarker for breast cancer detection
title_sort plasma dna as a potential biomarker for breast cancer detection
publisher Universitas Gadjah Mada
series Journal of the Medical Sciences
issn 0126-1312
2356-3931
publishDate 2016-12-01
description Breast cancer is a major malignancy among Indonesian women. It is often diagnosed in the later stages of cancer, which leads to poor prognosis and survival of the patients. This study investigated plasma DNA concentration as a potential biomarker for breast cancer. The benefit of using this detection is the cost-effectiveness and the samples can be collected from patients using non-invasive methods. Plasma samples were obtained from healthy controls (n=18) and cancer patients (n=22). Each sample was split into two equal portions for DNA isolation using two different methods for the NaI method and a commercially available kit (Qiagen/ QA) method. The DNA concentration was determined by using a GeneQuant spectrophotometer (Pharmacia). The t-test was used for statistical analysis, which was performed using the SPSS 17.0 software. Compared to the commercial method, extraction using NaI yielded higher DNA concentration, both from samples of healthy controls and cancer patients (p=0,008 and p=0.000, respectively). Furthermore, regardless of the isolation method used, the plasma DNA concentration was higher in healthy controls than in cancer cases (p=0,032 and p=0.005, for NaI and QA methods, respectively). In conclusion, isolation methods significantly affect DNA concentrations. The plasma DNA concentration of healthy controls is significantly higher than those of the cancer cases, suggesting that plasma DNA concentration might be a potential biomarker for breast cancer detection with less invasive sampling method than tissue biopsies.
topic plasma DNA
biomarker
detection
breast cancer
liquid biopsy
url https://jurnal.ugm.ac.id/bik/article/view/15931
work_keys_str_mv AT dewajanipurnomosari plasmadnaasapotentialbiomarkerforbreastcancerdetection
AT ulfahdianindrayani plasmadnaasapotentialbiomarkerforbreastcancerdetection
AT irianiwati plasmadnaasapotentialbiomarkerforbreastcancerdetection
AT diancaturinisulistyoningrum plasmadnaasapotentialbiomarkerforbreastcancerdetection
_version_ 1725865959981318144